Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 77,700
-700 (-0.89%)
Last updated: Apr 29, 2026, 2:29 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 579.25 billion as of April 29, 2026.
Market Cap
579.25B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
77,700.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 579.25B, an increase of 157.95%. That is a compound annual growth rate of 831.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 582.97B | 49.33% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.35T |
| Myung In Pharmaceutical LTD. | 838.04B |
| ImmuneOncia Therapeutics | 536.91B |
| CellBion | 479.90B |
| HEM Pharma | 421.96B |
| DAE HWA Pharmaceutical | 265.38B |
| NOVAREX | 264.12B |
| GREEN CROSS WellBeing | 251.98B |